<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(15)</volume><submitter>Yamada S</submitter><pubmed_abstract>Mutations in the &lt;i>LMNA&lt;/i> gene encoding Lamin A and C (Lamin A/C), major components of the nuclear lamina, cause laminopathies including dilated cardiomyopathy (DCM), but the underlying molecular mechanisms have not been fully elucidated. Here, by leveraging single-cell RNA sequencing (RNA-seq), assay for transposase-accessible chromatin using sequencing (ATAC-seq), protein array, and electron microscopy analysis, we show that insufficient structural maturation of cardiomyocytes owing to trapping of transcription factor TEA domain transcription factor 1 (TEAD1) by mutant Lamin A/C at the nuclear membrane underlies the pathogenesis of Q353R&lt;i>-LMNA-&lt;/i>related DCM. Inhibition of the Hippo pathway rescued the dysregulation of cardiac developmental genes by TEAD1 in &lt;i>LMNA&lt;/i> mutant cardiomyocytes. Single-cell RNA-seq of cardiac tissues from patients with DCM with the &lt;i>LMNA&lt;/i> mutation confirmed the dysregulated expression of TEAD1 target genes. Our results propose an intervention for transcriptional dysregulation as a potential treatment of &lt;i>LMNA&lt;/i>-related DCM.</pubmed_abstract><journal>Science advances</journal><pagination>eade7047</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10104473</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.</pubmed_title><pmcid>PMC10104473</pmcid><pubmed_authors>Hamano M</pubmed_authors><pubmed_authors>Kikkawa S</pubmed_authors><pubmed_authors>Ito M</pubmed_authors><pubmed_authors>Kubota M</pubmed_authors><pubmed_authors>Umezawa A</pubmed_authors><pubmed_authors>Katoh M</pubmed_authors><pubmed_authors>Morita H</pubmed_authors><pubmed_authors>Ko T</pubmed_authors><pubmed_authors>Imasaki T</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Katagiri M</pubmed_authors><pubmed_authors>Ikeuchi M</pubmed_authors><pubmed_authors>Toyoda M</pubmed_authors><pubmed_authors>Komuro I</pubmed_authors><pubmed_authors>Takeda N</pubmed_authors><pubmed_authors>Hatsuse S</pubmed_authors><pubmed_authors>Yamada T</pubmed_authors><pubmed_authors>Yamada S</pubmed_authors><pubmed_authors>Aburatani H</pubmed_authors><pubmed_authors>Takada S</pubmed_authors><pubmed_authors>Seki Y</pubmed_authors><pubmed_authors>Fujita K</pubmed_authors><pubmed_authors>Sassa T</pubmed_authors><pubmed_authors>Okuma H</pubmed_authors><pubmed_authors>Nitta R</pubmed_authors><pubmed_authors>Hayashi H</pubmed_authors><pubmed_authors>Sato M</pubmed_authors><pubmed_authors>Yamanishi Y</pubmed_authors><pubmed_authors>Nomura S</pubmed_authors><pubmed_authors>Uchiyama M</pubmed_authors><pubmed_authors>Toyooka K</pubmed_authors></additional><is_claimable>false</is_claimable><name>TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.</name><description>Mutations in the &lt;i>LMNA&lt;/i> gene encoding Lamin A and C (Lamin A/C), major components of the nuclear lamina, cause laminopathies including dilated cardiomyopathy (DCM), but the underlying molecular mechanisms have not been fully elucidated. Here, by leveraging single-cell RNA sequencing (RNA-seq), assay for transposase-accessible chromatin using sequencing (ATAC-seq), protein array, and electron microscopy analysis, we show that insufficient structural maturation of cardiomyocytes owing to trapping of transcription factor TEA domain transcription factor 1 (TEAD1) by mutant Lamin A/C at the nuclear membrane underlies the pathogenesis of Q353R&lt;i>-LMNA-&lt;/i>related DCM. Inhibition of the Hippo pathway rescued the dysregulation of cardiac developmental genes by TEAD1 in &lt;i>LMNA&lt;/i> mutant cardiomyocytes. Single-cell RNA-seq of cardiac tissues from patients with DCM with the &lt;i>LMNA&lt;/i> mutation confirmed the dysregulated expression of TEAD1 target genes. Our results propose an intervention for transcriptional dysregulation as a potential treatment of &lt;i>LMNA&lt;/i>-related DCM.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-18T14:52:04.36Z</modification><creation>2025-02-18T23:26:22.815Z</creation></dates><accession>S-EPMC10104473</accession><cross_references><pubmed>37058558</pubmed><doi>10.1126/sciadv.ade7047</doi></cross_references></HashMap>